Lipid nanoparticle-mediated mRNA delivery to CD34+ cells in rhesus monkeys
Nature Biotechnology · 2025-11 · 43 (11) · 1813-1820
DOI: 10.1038/s41587-024-02470-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature Biotechnology, online erschienen am 22.11.2024. Verfasst von Hyejin Kim und 20 weiteren Autor:innen. Beteiligte Einrichtung: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Nanoparticles, Hematopoietic Stem Cells, Antigens, CD34, Lipids. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIH HHS, Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.).
Abstract (Originalsprache)
Transplantation of ex vivo engineered hematopoietic stem cells (HSCs) can lead to robust clinical responses but carries risks of adverse events from bone marrow mobilization, chemotherapy conditioning and other factors. HSCs have been modified in vivo using lipid nanoparticles (LNPs) decorated with targeting moieties, which increases manufacturing complexity. Here we screen 105 LNPs without targeting ligands for effective homing to the bone marrow in mouse. We report an LNP named LNP67 that delivers mRNA to murine HSCs in vivo, primary human HSCs ex vivo and CD34+ cells in rhesus monkeys (Macaca mulatta) in vivo at doses of 0.25 and 0.4 mg kg-1. Without mobilization and conditioning, LNP67 can mediate delivery of mRNA to HSCs and their progenitor cells (HSPCs), as well as to the liver in rhesus monkeys, without serum cytokine activation. These data support the hypothesis that in vivo delivery to HSCs and HSPCs in nonhuman primates is feasible without targeting ligands.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, GA, USA.
- Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA, USA.
- Department of Chemical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
- California National Primate Research Center, University of California, Davis, Davis, CA, USA.
- Department of Pediatrics, University of California, Davis, Davis, CA, USA.
- Department of Cell Biology and Human Anatomy, University of California, Davis, Davis, CA, USA.
Förderung
- NCATS NIH HHS
- NIH HHS
- Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.)
- ODCDC CDC HHS
Zitieren
APA
Kim, H., Zenhausern, R., Gentry, K., Lian, L., Huayamares, S. G., Radmand, A., Loughrey, D., Podilapu, A. R., Hatit, M. Z. C., Ni, H., Li, A., Shajii, A., Peck, H. E., Han, K., Hua, X., Jia, S., Martinez, M., Lee, C., Santangelo, P. J., …, & Dahlman, J. E. (2025). Lipid nanoparticle-mediated mRNA delivery to CD34+ cells in rhesus monkeys. Nature Biotechnology, 43(11), 1813-1820. https://doi.org/10.1038/s41587-024-02470-2
Vancouver
Kim H, Zenhausern R, Gentry K, Lian L, Huayamares SG, Radmand A, et al. Lipid nanoparticle-mediated mRNA delivery to CD34+ cells in rhesus monkeys. Nature Biotechnology. 2025;43(11):1813-1820. doi:10.1038/s41587-024-02470-2
BibTeX
@article{Kim2025,
author = {Kim, Hyejin and Zenhausern, Ryan and Gentry, Kara and Lian, Liming and Huayamares, Sebastian G and Radmand, Afsane and Loughrey, David and Podilapu, Ananda R and Hatit, Marine Z C and Ni, Huanzhen and Li, Andrea and Shajii, Aram and Peck, Hannah E and Han, Keyi and Hua, Xuanwen and Jia, Shu and Martinez, Michele and Lee, Charles and Santangelo, Philip J and Tarantal, Alice and Dahlman, James E},
title = {Lipid nanoparticle-mediated mRNA delivery to CD34+ cells in rhesus monkeys},
journal = {Nature Biotechnology},
year = {2025},
volume = {43},
number = {11},
pages = {1813--1820},
doi = {10.1038/s41587-024-02470-2}
}
EUVIMED